Research Projects
Combination of epigenetic modifiers and AAV vector-based gene immunotherapy for the treatment of pancreatic cancer
Researcher | Principal Investigator
Tumor Evasion and New Targets Research Group
Research Division
Cancer Division
Research program
Solid Tumors
Research group
Tumor Evasion and New Targets
Project information
“Combination of epigenetic modifiers and AAV-based gene therapy for the treatment of pancreatic cancer” is a project by the Tumor Evasion and New Targets research group, part of the Solid Tumors research program.
Project PID2024-160227OB-I00 funded by:
- Convocation: Proyectos de Generación de Conocimiento 2024
- Reference: PID2024-160227OB-I00
- Start date: September 1, 2025
- End date: August 31, 2028
- Nature of project: National
Need more information?
If you are interested in learning more about our research, please contact us.